Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
about
The anti-protozoan drug nifurtimox preferentially inhibits clonogenic tumor cells under hypoxic conditions.Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.A comparison of toxicity and toxicokinetics in rats and dogs following twenty-eight-day, repeat-dose oral administration of nifurtimox
P2860
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@ast
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@en
type
label
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@ast
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@en
prefLabel
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@ast
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@en
P2093
P2860
P1476
Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.
@en
P2093
Gernot Bruchelt
Rupert Handgretinger
Ursula Holzer
P2860
P304
P356
10.1080/15384047.2015.1070987
P577
2015-07-15T00:00:00Z